The compound was first described in the 1990s by Predrag Sikiric and colleagues at the University of Zagreb, Croatia
Building on these findings, our recent study demonstrated that sulforaphane prevented ASD-associated phenotypes induced by valproic acid, including oxidative stress, synaptic loss and neural activity disruption, highlighting sulforaphanes potential as a preventative strategy against early life ASD risk (Bessetti et al., 2025)
In addition to its basic role in slowing down aging, GSH has a role in the metabolism of substances that cause cancer, protein synthesis, DNA repair, enzyme activation, immune response regulation, and memory maintenance
Whether GHK-Cu is appropriate for you is a clinical determination made by a licensed provider during evaluation
GLP-1s approved for weight loss show dramatic results: In clinical trials, once-a-week Wegovy (semaglutide) for 68 weeks led to an average weight loss of 14.9% from baseline body weight, while 86.4% of all participants taking Wegovy saw clinically significant weight lossgenerally defined as losing 5% or more of baseline body weight during the trial
